Vanderbilt Health researchers and colleagues have isolated human monoclonal antibodies from previously infected individuals ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, ...
VYD2311 met all primary and secondary endpoints comparing VYD2311 to an mRNA-based COVID-19 vaccine, demonstrating VYD2311 safety and ...
AI antibody discovery can be accelerated by integrating computational prediction with experimental production, validation, ...
Further development could lead to the first monoclonal antibody therapy against the highly infectious measles respiratory ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough ...
Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase Ia part of a global clinical trial of HMPL-A830 in patients with unresectable, ...
This article explores how advances in antibody engineering are moving immunotherapy beyond traditional monoclonal antibodies to bispecific and trispecific formats and logic-gated designs.
Recently, the 'Key Rules for Inter-provincial Joint Procurement of Monoclonal Antibody Drugs Led by Anhui Province (Draft for Comments)' has been circulating within the industry. This proposal ...
Now, in a new study published in Nature Microbiology, researchers have found that the bacterium Bacillus subtilis can ...
End-to-end In-house Technology Builds Independent, High-performance Flow Cytometry Antibody Solutions HUSTON, TX, ...
Global analysis of more than 60,000 RSV viral sequences reveals that resistance to monoclonal antibodies remains rare.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results